Document Actions
Steering Committee Selects Patient Representatives
Drs. James Ferguson and Briggs Morrison, Co-chairs of the CTTI Steering Committee, are pleased to announce that Michael Katz and Jane Perlmutter have been selected as the patient representatives to the CTTI Steering Committee.
The patient representatives serve an important role in providing valuable perspectives and input to Steering Committee discussions and decisions. They also serve as liaisons with the patient advocacy community. Mr. Katz and Ms. Perlmutter both have considerable experience as patient advocates and will contribute significantly to our efforts to improve the quality and efficiency of clinical trials.
Mike Katz has worked as a patient advocate for the past fifteen years, first for multiple myeloma, of which he is a 19-year survivor, and then more broadly across all cancers. He has contributed materially to the development and design of clinical trials, as well as ethical and operational issues. Mr. Katz currently chairs the Eastern Cooperative Oncology Group (ECOG) Patient Representative Committee and the Coalition of Cancer Cooperative Groups’ Patient Advisory Board.
Jane Perlmutter was diagnosed with cancer in 1985 and is a cancer survivor and advocate. She is a member of the Clinical Trials Summit’s Informed Consent Steering Committee and the Cancer and Leukemia Group B (CALGB) Breast Cancer Committee. Ms. Perlmutter has been a stakeholder reviewer for the American Cancer Society (ACS), the US Department of Defense’s external research program, and the California Breast Cancer Research Program.
We appreciate the interest received from many impressive applicants for the patient representative positions. We look forward to working with Mr. Katz, Ms. Perlmutter, and Nancy Roach (patient representative on the CTTI Executive Committee) to engage more patient advocates in CTTI activities.
View Entire Calendar